Coronavirus (COVID-19) Update: Daily Roundup October 5, 2020

The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:

FDA awarded a new research contract to the Stanford University School of Medicine to perform an in-depth analysis of tissue samples to learn more about how SARS-CoV-2—the virus that causes COVID-19—affects different systems in the body, and identify immune correlates. This regulatory science project could potentially help inform development and evaluation of medical countermeasures for COVID-19.
Testing updates:
- As of today, 270 tests are authorized by FDA under EUAs; these include 213 molecular tests, 52 antibody tests, and 5 antigen tests.